FDA & ICH
WCG Clinical | Insights
The FDA Accepts ICH E11A on Pediatric Extrapolation: How Does This Impact Your Pediatric Study?
Blog Posts
WCG Clinical | Insights
Sunsetting FDA Enforcement Discretion of Laboratory Developed Tests
Blog Posts
WCG Clinical | Insights
Function over Form: Assessing Different Consent Form Formats
Whitepapers
WCG Clinical | Insights
Research and Cannabis: Ethical Research in a Changing Regulatory Landscape
Whitepapers
WCG Clinical | Insights
What Can Institutions with Local IRBs Do to Prepare for the Proposed FDA Single IRB Mandate?
Whitepapers
WCG Clinical | Insights
Understanding the FDA’s new proposed regulations on human subject research and their impact on your clinical trial plans
Videos
WCG Clinical | Insights
Assessing Potential Risks in the Consideration of IND Exemption Criteria
Blog Posts
WCG Clinical | Insights
Defining “Minimal Risk” in Clinical Research
Blog Posts
WCG Clinical | Insights
Which comes first – IRB or IBC approval?
Blog Posts
WCG Clinical | Insights